Effect Of COVID-19 on breast cancer treatment and its outcome
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhereHealth Condition 2: C509- Malignant neoplasm of breast of unspecified site
- Registration Number
- CTRI/2020/11/028969
- Lead Sponsor
- A
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
INCLUSION CRITERIA COVID Case Cohort
1. Histologically confirmed breast cancer
2. Age more than 18years, female or male
3. Registered at TMC during the COVID-19 Mumbai lockdown starting from 25th March 2020
Or
Registered in TMC after 1st May 2019 and still receiving or expected to be receiving active treatment (except oral hormone therapy) during the lockdown in Mumbai
INCLUSION CRITERIA Control Cohort:
1. Histologically confirmed primary breast cancer
2. Age more than 18years, female or male
3. Registered at TMC during the period 1st February to 30th April 2019
EXCLUSION CRITERIA CASES
1. Registered in TMC after partial or full treatment outside (except incision/excision biopsy)
2. Not willing and providing consent for telephonic interview
EXCLUSION CRITERIA CONTROLS
1. Registered in TMC after partial or full treatment outside (except incision/excision biopsy)
2. Not willing and providing consent for telephonic interview
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To determine the proportion of breast cancer patients who could not receive the TMC Standard of Care (SOC) multimodality treatment in the COVID and Pre-COVID cohortsTimepoint: 6 months - initial analysis and then 2 and 5 years
- Secondary Outcome Measures
Name Time Method